Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahraa S Al-Ahmady

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Delivery|February 23, 2018
Selective drug delivery approaches to lesioned brain through blood brain barrier disruptionZahraa S Al-Ahmady
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermiaZahraa S Al-Ahmady, Olivier Chaloin, Kostas Kostarelos
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2022
Re-directing nanomedicines to the spleen: A potential technology for peripheral immunomodulationSatinderdeep Kaur, Stuart M Allan, Zahraa S Al-Ahmady
International Journal of Cancer|February 3, 2015
Triggered doxorubicin release in solid tumors from thermosensitive liposome-peptide hybrids: Critical parameters and therapeutic efficacyZahraa S Al-Ahmady, Cheryl L Scudamore, Kostas Kostarelos
Biomaterials|March 31, 2012
Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermiaWafa' T Al-Jamal, Zahraa S Al-Ahmady, Kostas Kostarelos
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2018
Formation of protein corona in vivo affects drug release from temperature-sensitive liposomesZahraa S Al-Ahmady, Marilena Hadjidemetriou, James Gubbins, et al.
International Journal of Pharmaceutics|December 3, 2014
Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agentNeus Lozano, Zahraa S Al-Ahmady, Nicolas S Beziere, et al.
Ecotoxicology and Environmental Safety|February 7, 2024
Maternal exposure to PM<sub>2.5</sub> induces cognitive impairment in offspring via cerebellar neuroinflammation and oxidative stressJiajia Zhang, Yingying Yang, Zahraa S Al-Ahmady, et al.
ACS Nano|November 7, 2019
Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic OpportunitiesZahraa S Al-Ahmady, Dhifaf Jasim, Sabahuddin Syed Ahmad, et al.
ACS Nano|August 4, 2012
Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivoZahraa S Al-Ahmady, Wafa' T Al-Jamal, Jeroen V Bossche, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Delivery|February 23, 2018
Selective drug delivery approaches to lesioned brain through blood brain barrier disruptionZahraa S Al-Ahmady
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermiaZahraa S Al-Ahmady, Olivier Chaloin, Kostas Kostarelos
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2022
Re-directing nanomedicines to the spleen: A potential technology for peripheral immunomodulationSatinderdeep Kaur, Stuart M Allan, Zahraa S Al-Ahmady
International Journal of Cancer|February 3, 2015
Triggered doxorubicin release in solid tumors from thermosensitive liposome-peptide hybrids: Critical parameters and therapeutic efficacyZahraa S Al-Ahmady, Cheryl L Scudamore, Kostas Kostarelos
Biomaterials|March 31, 2012
Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermiaWafa' T Al-Jamal, Zahraa S Al-Ahmady, Kostas Kostarelos
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2018
Formation of protein corona in vivo affects drug release from temperature-sensitive liposomesZahraa S Al-Ahmady, Marilena Hadjidemetriou, James Gubbins, et al.
International Journal of Pharmaceutics|December 3, 2014
Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agentNeus Lozano, Zahraa S Al-Ahmady, Nicolas S Beziere, et al.
Ecotoxicology and Environmental Safety|February 7, 2024
Maternal exposure to PM<sub>2.5</sub> induces cognitive impairment in offspring via cerebellar neuroinflammation and oxidative stressJiajia Zhang, Yingying Yang, Zahraa S Al-Ahmady, et al.
ACS Nano|November 7, 2019
Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic OpportunitiesZahraa S Al-Ahmady, Dhifaf Jasim, Sabahuddin Syed Ahmad, et al.
ACS Nano|August 4, 2012
Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivoZahraa S Al-Ahmady, Wafa' T Al-Jamal, Jeroen V Bossche, et al.
Pageof 2